Skip to main content
Top
Published in: International Journal of Hematology 1/2011

01-07-2011 | Progress in Hematology

Guest editorial: tackling the problems of hematopoietic stem cell aging

Author: Tao Cheng

Published in: International Journal of Hematology | Issue 1/2011

Login to get access

Excerpt

Tissue degeneration is a hallmark for the aging of an organism. With the capabilities of self-renewal and differentiation, stem cells are largely responsible for tissue maintenance and regeneration. Therefore, stem cells must be directly involved in organismal aging. In fact, many types of adult stem cells have been reported to be associated with tissue degeneration in a variety of species including human. Research on stem cell aging has been increasingly emphasized in recent years. Since 2009, there have been two international conferences held in Germany on stem cell aging (http://​www.​ageing-research.​de/​index.​html). There was a special session on stem cell aging at the ISSCR meeting as well (http://​www.​isscr.​org/​/​AM/​Template.​cfm?​Section=​Home). Funding on stem cell aging has also been increased in some countries. For example, the Chinese government recently funded a national key research program on stem cell aging (http://​www.​most.​gov.​cn/​tztg/​201008/​t20100806_​78777.​htm). …
Literature
1.
go back to reference Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol. 2002;3(4):329–33. (review).PubMedCrossRef Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol. 2002;3(4):329–33. (review).PubMedCrossRef
2.
go back to reference de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood. 1997;89(5):1543–50.PubMed de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood. 1997;89(5):1543–50.PubMed
3.
go back to reference Harrison DE, Astle CM, Delaittre JA. Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging. J Exp Med. 1978;147(5):1526–31.PubMedCrossRef Harrison DE, Astle CM, Delaittre JA. Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging. J Exp Med. 1978;147(5):1526–31.PubMedCrossRef
4.
go back to reference Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med. 1996;2(9):1011–6.PubMedCrossRef Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med. 1996;2(9):1011–6.PubMedCrossRef
5.
go back to reference Sudo K, Ema H, Morita Y, Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med. 2000;192(9):1273–80.PubMedCrossRef Sudo K, Ema H, Morita Y, Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med. 2000;192(9):1273–80.PubMedCrossRef
Metadata
Title
Guest editorial: tackling the problems of hematopoietic stem cell aging
Author
Tao Cheng
Publication date
01-07-2011
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2011
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0890-z

Other articles of this Issue 1/2011

International Journal of Hematology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine